Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INVITED Trial: Influenza Vaccination in Early Type 1 Diabetes
NCT05585983Phase 4Recruiting
- Sponsor
- Aarhus University Hospital
- Start
- Dec 2022
- Primary completion
- May 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of quadrivalent influenza vaccine in type 1 diabetes mellitus (T1D), sponsored by Aarhus University Hospital. Started Dec 2022; status: recruiting.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05585983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585983.